Preferred Label : Rivaroxaban;

MeSH definition : A morpholine and thiophene derivative that functions as a FACTOR XA INHIBITOR and is used in the treatment and prevention of DEEP-VEIN THROMBOSIS and PULMONARY EMBOLISM. It is also used for the prevention of STROKE and systemic embolization in patients with non-valvular ATRIAL FIBRILLATION, and for the prevention of atherothrombotic events in patients after an ACUTE CORONARY SYNDROME.;

MeSH synonym : 5-chloro-N-(((5S)-2-oxo-3-(4-(3-oxomorpholin-4-yl)phenyl)-1,3-oxazolidin-5-yl)methyl)thiophene-2-carboxamide;

MeSH hyponym : BAY 59-7939; xarelto; BAY 59 7939; BAY 597939;

Wikipedia link : https://en.wikipedia.org/wiki/Rivaroxaban;

Is substance : O;

UNII : 9NDF7JZ4M3;

Details


Main resources

You can consult :

A morpholine and thiophene derivative that functions as a FACTOR XA INHIBITOR and is used in the treatment and prevention of DEEP-VEIN THROMBOSIS and PULMONARY EMBOLISM. It is also used for the prevention of STROKE and systemic embolization in patients with non-valvular ATRIAL FIBRILLATION, and for the prevention of atherothrombotic events in patients after an ACUTE CORONARY SYNDROME.

https://ansm.sante.fr/tableau-marr/rivaroxaban
2023
false
false
false
France
French
Rivaroxaban
risk management
guidelines for drug use
continuity of patient care
administration, oral
medication errors
hemorrhage
Drug-Related side effects and adverse reactions
Rivaroxaban
package leaflet
video recording

---
https://www.ema.europa.eu/en/medicines/human/EPAR/rivaroxaban-mylan
2022
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
Rivaroxaban
Rivaroxaban
rivaroxaban
drugs, generic

---
https://www.has-sante.fr/jcms/p_3375779/fr/xarelto-rivaroxaban
2022
false
false
false
France
treatment outcome
insurance, health, reimbursement
Rivaroxaban
rivaroxaban
Factor Xa Inhibitors
adult
drug therapy, combination
aspirin
Atherothrombosis
lower extremity
arterial occlusive diseases
Lower limb revascularization
postoperative care
Product containing precisely rivaroxaban 2.5 milligram/1 each conventional release oral tablet (clinical drug)
administration, oral
evaluation of the transparency committee

---
https://www.has-sante.fr/jcms/p_3287831/fr/xarelto-1-mg/ml-rivaroxaban
2021
France
evaluation of the transparency committee
rivaroxaban
Rivaroxaban
xarelto

---
https://www.has-sante.fr/jcms/p_3272782/fr/xarelto-rivaroxaban-evenements-thromboemboliques-veineux-etev-pediatrique
2021
false
false
false
France
treatment outcome
insurance, health, reimbursement
administration, oral
rivaroxaban
child
tablets
Granules for Oral Suspension Dosage Form
venous thromboembolism
venous thromboembolism
recurrence
guidelines for drug use
Rivaroxaban
Factor Xa Inhibitors
Factor Xa Inhibitors
evaluation of the transparency committee
Rivaroxaban

---
https://ansm.sante.fr/tableau-atu-rtu/xarelto-1-mg-ml-granules-pour-suspension-buvable
2021
false
false
false
France
French
guidelines for drug use
package leaflet
summary of product characteristics
Rivaroxaban
Rivaroxaban

---
https://www.usherbrooke.ca/baladocritique/archives/episode-34-etude-voyager-pad/
2020
Canada
sound
peripheral arterial disease
data collection
Artery
rivaroxaban
Disease
acetylsalicylic acid
Diseases
Rivaroxaban
diastolic pressure
aspirin
travel
disease of artery, nos
due to
neovascularization
blood pressure

---
https://www.ema.europa.eu/en/medicines/human/EPAR/rivaroxaban-accord
2020
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
Rivaroxaban
Rivaroxaban
drugs, generic
rivaroxaban
Product containing precisely rivaroxaban 10 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely rivaroxaban 15 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely rivaroxaban 20 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely rivaroxaban 2.5 milligram/1 each conventional release oral tablet (clinical drug)
administration, oral
Factor Xa Inhibitors
Factor Xa Inhibitors
adult
aged
deep vein thrombosis
deep vein thrombosis
recurrence
pulmonary embolism
pulmonary embolism
venous thromboembolism
postoperative complications
postoperative venous thromboembolism
arthroplasty, replacement, knee
arthroplasty, replacement, hip
stroke
Systemic embolism
embolism
atrial fibrillation
myocardial infarction
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
venous thrombosis
venous thrombosis

---
https://www.has-sante.fr/jcms/p_3212998/fr/xarelto
2020
false
false
false
France
rivaroxaban
insurance, health, reimbursement
treatment outcome
administration, oral
deep vein thrombosis
deep vein thrombosis
pulmonary embolism
pulmonary embolism
recurrence
stroke
atrial fibrillation
Systemic embolism
embolism
postoperative venous thromboembolism
Factor Xa Inhibitors
venous thromboembolism
evaluation of the transparency committee
Rivaroxaban
venous thrombosis
venous thrombosis

---
https://www.has-sante.fr/jcms/p_3114491/fr/xarelto
2019
false
false
false
France
insurance, health, reimbursement
treatment outcome
administration, oral
Factor Xa Inhibitors
drug therapy, combination
aspirin
adult
Atherothrombosis
acute coronary syndrome
coronary disease
peripheral arterial disease
Atherothrombosis prophylaxis
rivaroxaban
Clopidogrel
ticlopidine
thrombosis
evaluation of the transparency committee
xarelto
Rivaroxaban
Rivaroxaban

---
https://ansm.sante.fr/informations-de-securite/Anticoagulants-Oraux-Directs-AODs-apixaban-Eliquis-R-rivaroxaban-Xarelto-R-dabigatran-Pradaxa-R-et-edoxaban-Lixiana-R-Roteas-R-non-recommandes-chez-les-patients-presentant-un-Syndrome-des-Antiphospholipides-SAPL
2019
false
false
false
France
French
pharmacovigilance note
guidelines for drug use
administration, oral
apixaban
Rivaroxaban
edoxaban
anticoagulants
Dabigatran
recurrence
risk
antiphospholipid syndrome
thrombosis
thrombosis
pyrazoles
pyridones
pyridines
thiazoles

---
https://www.minerva-ebp.be/FR/Article/2183
2019
false
true
false
false
Belgium
cardiovascular diseases
drug therapy, combination
treatment outcome
adult
hemorrhage
Rivaroxaban
aspirin
Factor Xa Inhibitors
platelet aggregation inhibitors
randomized controlled trials as topic
risk assessment
cardiovascular diseases
cardiovascular diseases
Factor Xa Inhibitors
platelet aggregation inhibitors
critical appraisal or critical reading
cardiovascular prevention
Rivaroxaban
secondary prevention
aspirin

---
https://pharmactuel.com/index.php/pharmactuel/article/view/1262
2019
false
false
false
Canada
comparative effectiveness research
venous thromboembolism
venous thrombosis
postoperative complications
platelet aggregation inhibitors
Factor Xa Inhibitors
pulmonary embolism
hemorrhage
critical appraisal or critical reading
aspirin
arthroplasty, replacement, knee
Rivaroxaban
arthroplasty, replacement, hip

---
https://www.has-sante.fr/portail/jcms/c_2826828/fr/xarelto
2018
false
false
false
false
France
French
evaluation of the transparency committee
xarelto
Rivaroxaban

---
http://canadiensensante.gc.ca/recall-alert-rappel-avis/hc-sc/2018/68616a-fra.php
2018
false
false
false
Canada
French
English
Transcatheter Aortic Valve Replacement
pharmacovigilance note
Rivaroxaban
thromboembolism
hemorrhage
Factor Xa Inhibitors
rivaroxaban
early termination of clinical trials

---
https://www.has-sante.fr/portail/jcms/c_2888447/fr/xarelto
2018
false
false
false
France
recurrence
pulmonary embolism
venous thrombosis
administration, oral
Factor Xa Inhibitors
deep vein thrombosis
treatment outcome
deep vein thrombosis
pulmonary embolism
rivaroxaban
evaluation of the transparency committee
xarelto
Rivaroxaban
venous thrombosis

---
https://ansm.sante.fr/informations-de-securite/rivaroxaban-xarelto-essai-clinique-arrete-prematurement-chez-des-patients-ayant-beneficie-dun-remplacement-valvulaire-aortique-percutane
2018
false
false
false
France
French
Rivaroxaban
Percutaneous Aortic Valve Replacement
early termination of clinical trials
Transcatheter Aortic Valve Replacement
thromboembolism
chemoprevention
pharmacovigilance note
guidelines for drug use
rivaroxaban
drug therapy, combination
Factor Xa Inhibitors
thromboembolism
hemorrhage
product surveillance, postmarketing

---
https://www.usherbrooke.ca/baladocritique/archives/episode-15-etude-epcat-ii/
2018
false
false
false
false
Canada
French
sound
aspirin
Rivaroxaban
orthopedics
hip prosthesis
knee prosthesis
thromboembolism
anticoagulants
Acanthocytosis
Orthopedic Surgeons
acetylsalicylic acid
elective
data collection
orthopedic surgery
episode of
rivaroxaban
Elective Surgical Procedures
operative procedure, nos
Orthopedic surgery
Surgery

---
https://www.pharmactuel.com/index.php/pharmactuel/article/view/1205
2018
false
false
false
Canada
French
critical appraisal or critical reading
comparative effectiveness research
platelet aggregation inhibitors
Factor Xa Inhibitors
aspirin
venous thromboembolism
Rivaroxaban

---
https://www.has-sante.fr/portail/jcms/c_2826828/fr/xarelto-15-mg-20-mg-fanv
2018
false
false
false
false
France
French
evaluation of the transparency committee
xarelto
Rivaroxaban

---
http://kce.fgov.be/fr/publication/report/anticoagulation-et-fibrillation-auriculaire
2017
false
false
false
Belgium
French
anticoagulants
anticoagulants
atrial fibrillation
treatment outcome
stroke
continuity of patient care
Cost-Benefit analysis
medication adherence
risk assessment
hemorrhage
vitamin K
antivitamins K
Rivaroxaban
edoxaban
Dabigatran
apixaban
Factor Xa Inhibitors
antithrombins
belgium
technical report
drug information
comparative study
anticoagulants
economic evaluation
drug monitoring
new oral anticoagulant
indenes
4-hydroxycoumarins
pyridines
thiazoles
pyrazoles
pyridones

---
https://www.has-sante.fr/portail/jcms/c_2772419/fr/xarelto
2017
false
false
false
France
French
evaluation of the transparency committee
Rivaroxaban

---
https://www.usherbrooke.ca/baladocritique/archives/episode-10-etude-compass/
2017
false
true
false
false
Canada
French
sound
Rivaroxaban
cardiovascular diseases
aspirin
Diseases of the cardiovascular system
Rivaroxaban
data collection
Perianal abscess
stable
rivaroxaban
cardiovascular diseases
disease of cardiovascular system, nos
episode of
Diseases
acetylsalicylic acid

---
http://www.sudoc.fr/224735926
2017
false
false
false
France
French
dissertations, academic
rivaroxaban
hospital, nos
treaties
therapeutics
Rivaroxaban
Comminuted fracture
Avulsion fracture
hospitals
international cooperation

---
http://www.has-sante.fr/portail/jcms/c_2633894/fr/xarelto
http://www.has-sante.fr/portail/jcms/c_1241652/xarelto
http://www.has-sante.fr/portail/jcms/c_2633894/fr/xarelto-rivaroxaban-anticoagulant-par-voie-orale
2016
false
France
French
secondary prevention
Factor Xa Inhibitors
evaluation of the transparency committee
Rivaroxaban
recurrence
pulmonary embolism
guidelines for drug use
administration, oral
insurance, health, reimbursement
venous thrombosis
pulmonary embolism
venous thrombosis
adult
deep vein thrombosis
deep vein thrombosis
acute disease
treatment outcome
anticoagulants
factor xa
rivaroxaban

---
http://www.centreantipoisons.be/professionnels-de-la-sant/articles-pour-professionnels-de-la-sant/nouveaux-anticoagulants-par-voie
2016
false
false
false
Belgium
French
Dutch
practice guideline
administration, oral
Rivaroxaban
rivaroxaban
anticoagulants
apixaban
Factor Xa Inhibitors
hemorrhage
hemorrhage
hemorrhage
apixaban
dabigatran etexilate
Dabigatran
antithrombins
hospitalization
ambulatory care
pyrazoles
pyridones

---
https://www.revmed.ch/RMS/2016/RMS-N-542/Anticoagulants-oraux-directs-ACOD-une-aide-a-la-prescription-dans-la-pratique-quotidienne
2016
false
false
false
Switzerland
French
journal article
venous thromboembolism
antithrombins
administration, oral
atrial fibrillation
Evidence-Based medicine
guidelines for drug use
recurrence
venous thromboembolism
antithrombins
Direct factor Xa inhibitors
Factor Xa Inhibitors
Factor IIa
dabigatran etexilate
Dabigatran
Rivaroxaban
apixaban
edoxaban
drug interactions
continuity of patient care
clinical chemistry tests
kidney function tests
hemorrhage
surgical procedures, operative
heparin
antivitamins K
patient safety
factor IIa
prothrombin
pyrazoles
pyridones
pyridines
thiazoles
indenes
4-hydroxycoumarins
vitamin K
vitamin K

---
https://www.revmed.ch/RMS/2016/RMS-N-529/Anticoagulants-oraux-directs-quelques-considerations-pratiques
2016
false
false
false
Switzerland
French
journal article
administration, oral
anticoagulants
thromboembolism
thromboembolism
Direct factor Xa inhibitors
direct thrombin inhibitors
aged
neoplasms
liver cirrhosis
obesity
continuity of patient care
drug interactions
antidotes
stroke
treatment outcome
anticoagulants
Dabigatran
Rivaroxaban
apixaban
edoxaban
anticoagulants
Contraindications, Procedure
pyrazoles
pyridones
pyridines
thiazoles
Contraindications, Drug

---
http://www.ameli.fr/l-assurance-maladie/statistiques-et-publications/etudes-en-sante-publique/etudes-pharmaco-epidemiologiques/nouveaux-anticoagulants-naco-et-risques-associes.php
2015
false
false
false
France
French
technical report
antivitamins K
hemorrhage
stroke
atrial fibrillation
antithrombins
anticoagulants
anticoagulotherapy
Dabigatran
Rivaroxaban

---
Rivaroxaban and liver injury - Review article
http://www.hc-sc.gc.ca/dhp-mps/medeff/bulletin/hpiw-ivps_2015-08-fra.php#review
2015
false
false
false
Canada
French
English
rivaroxaban
journal article
pharmacovigilance note
anticoagulants
administration, oral
factor xa
Chemical and Drug Induced Liver Injury
venous thromboembolism
venous thromboembolism
stroke
embolism
Factor Xa Inhibitors
Rivaroxaban

---
http://www.academie-medecine.fr/rapport-sur-les-anticoagulants-oraux-directs-aod-anterieurement-appeles-nouveaux-anticoagulants-oraux-ou-naco/
http://www.academie-medecine.fr/wp-content/uploads/2014/06/aod2805.pdf
2014
false
false
false
false
France
French
anticoagulants
administration, oral
technical report
anticoagulants
drug interactions
thromboembolism
anticoagulants
pyridines
apixaban
pyrazoles
pyridones
atrial fibrillation
antithrombins
thiazoles
edoxaban
acute coronary syndrome
anticoagulants
vitamin K
orthopedic procedures
anticoagulotherapy
Dabigatran
Dabigatran
Rivaroxaban

---
http://www.cfp.ca/content/60/11/e504.full
2014
false
false
false
Canada
French
anticoagulants
journal article
antithrombins
apixaban
stroke
atrial fibrillation
venous thromboembolism
comparative study
treatment outcome
case reports
warfarin
anticoagulants
anticoagulotherapy
Rivaroxaban
Dabigatran
pyrazoles
pyridones

---
http://www.cfp.ca/content/60/11/e512.full
2014
false
false
false
Canada
French
journal article
anticoagulants
case reports
drug interactions
stroke
atrial fibrillation
venous thromboembolism
apixaban
food-drug interactions
preoperative care
anticoagulotherapy
Dabigatran
Rivaroxaban
pyrazoles
pyridones

---
https://www.revmed.ch/RMS/2014/RMS-N-416/Pourquoi-quand-et-comment-doser-les-nouveaux-anticoagulants-oraux
2014
false
false
false
Switzerland
French
journal article
thromboembolism
continuity of patient care
drug monitoring
anticoagulants
administration, oral
rivaroxaban
apixaban
dabigatran etexilate
apixaban
risk factors
blood coagulation tests
kidney failure, chronic
factor xa
antithrombins
Factor Xa Inhibitors
Rivaroxaban
Dabigatran
pyrazoles
pyridones

---
https://www.revmed.ch/RMS/2014/RMS-N-416/Nouveaux-anticoagulants-oraux-donnees-pharmacologiques-a-connaitre-pour-la-pratique-clinique
2014
false
false
false
Switzerland
French
journal article
anticoagulants
administration, oral
antithrombins
factor xa
apixaban
thromboembolism
thromboembolism
drug interactions
renal insufficiency
hepatic insufficiency
aged
obesity
anticoagulants
antithrombins
Factor Xa Inhibitors
anticoagulotherapy
Rivaroxaban
Dabigatran
pyrazoles
pyridones

---
http://www.has-sante.fr/portail/jcms/c_2008295/fr/xarelto
2014
true
France
French
evaluation of the transparency committee
postoperative venous thromboembolism
venous thromboembolism
postoperative complications
arthroplasty, replacement, knee
arthroplasty, replacement, hip
pulmonary embolism
pulmonary embolism
venous thrombosis
venous thrombosis
deep vein thrombosis
deep vein thrombosis
secondary prevention
Factor Xa Inhibitors
Rivaroxaban
administration, oral
insurance, health, reimbursement
anticoagulants
factor xa
stroke
embolism
adult
atrial fibrillation
risk factors
aged
treatment outcome
rivaroxaban

---
https://www.jle.com/fr/revues/medecine/met/e-docs/00/04/99/39/resume.phtml
2014
false
France
French
atrial fibrillation
anticoagulants
journal article
thrombosis
vitamin K
drug interactions
practice guideline
aged
risk assessment
apixaban
edoxaban
pyridines
thiazoles
pyrazoles
pyridones
antithrombins
anticoagulotherapy
Rivaroxaban
Dabigatran
antivitamins K
indenes
4-hydroxycoumarins

---
http://www.sciencedirect.com/science/article/pii/S0755498214002590
2014
false
false
false
France
French
atrial fibrillation
anticoagulants
administration, oral
anticoagulants
drug interactions
journal article
dabigatran etexilate
rivaroxaban
apixaban
apixaban
edoxaban
warfarin
factor xa
antithrombins
treatment outcome
renal insufficiency
age factors
Direct current cardioversion (procedure)
myocardial infarction
surgical procedures, operative
Factor Xa Inhibitors
anticoagulotherapy
Dabigatran
Rivaroxaban
pyridines
pyrazoles
pyridones
thiazoles

---
http://www.pharmactuel.com/index.php/pharmactuel/article/view/950
2014
false
false
false
false
Canada
French
rivaroxaban
critical appraisal or critical reading
administration, oral
treatment outcome
anticoagulants
anticoagulants
factor xa
Bias
Factor Xa Inhibitors
Rivaroxaban
Rivaroxaban
pulmonary embolism

---
https://www.revmed.ch/RMS/2013/RMS-392/Questions-et-reponses-sur-l-utilisation-du-rivaroxaban-Xarelto-dans-la-pratique
2013
false
false
false
Switzerland
anticoagulants
journal article
anticoagulants
anticoagulotherapy
Rivaroxaban
Rivaroxaban

---
http://www.has-sante.fr/portail/jcms/c_1700943/fr/point-sur-lutilisation-des-nouveaux-anticoagulants-oraux
2013
false
France
French
anticoagulotherapy
Rivaroxaban
Dabigatran
anticoagulants
administration, oral
dabigatran etexilate
rivaroxaban
apixaban
apixaban
thromboembolism
thromboembolism
product surveillance, postmarketing
hemorrhage
practice guidelines as topic
drug information
pyrazoles
pyridones

---
https://medicalforum.ch/fr/detail/doi/fms.2013.01679/
2013
false
Switzerland
French
anticoagulotherapy
Rivaroxaban
Dabigatran
dabigatran etexilate
anticoagulants
administration, oral
rivaroxaban
apixaban
apixaban
patient compliance
surgical procedures, operative
venous thromboembolism
atrial fibrillation
thromboembolism
renal insufficiency
perioperative period
hemorrhage
risk management
journal article
pyrazoles
pyridones

---
https://ansm.sante.fr/uploads/2021/03/12/f6f2d53a601a3f25c5e0eb84dff9dd28.pdf
2013
false
France
French
Factor Xa Inhibitors
anticoagulotherapy
Rivaroxaban
Rivaroxaban
Dabigatran
Dabigatran
anticoagulants
anticoagulants
anticoagulants
administration, oral
hemorrhage
risk
continuity of patient care
thrombin
factor xa
apixaban
examination questions
patient education handout
drug information
rivaroxaban
apixaban
dabigatran etexilate
pyrazoles
pyridones

---
http://www.has-sante.fr/portail/jcms/c_1626282/en/fibrillation-auriculaire-non-valvulaire-quelle-place-pour-les-anticoagulants-oraux-non-antivitamine-k-apixaban-eliquis-dabigatran-pradaxa-et-rivaroxaban-xarelto-fiche-bum
http://www.has-sante.fr/portail/jcms/c_1626266/en/bon-usage-anticoagulants-oraux-non-avk
2013
true
France
French
antivitamins K
anticoagulotherapy
Rivaroxaban
Dabigatran
atrial fibrillation
anticoagulants
administration, oral
apixaban
dabigatran etexilate
apixaban
guidelines for drug use
rivaroxaban
thromboembolism
hemorrhage
anticoagulants
antivitamins K
risk factors
drug interactions
patient compliance
evaluation of the transparency committee
indenes
4-hydroxycoumarins
vitamin K
pyrazoles
pyridones

---
http://www.has-sante.fr/portail/jcms/c_1615053/fr/xarelto
http://www.has-sante.fr/portail/jcms/c_1615052/fr/xarelto-12062013-avis-ct12699
2013
false
France
French
secondary prevention
Factor Xa Inhibitors
Rivaroxaban
Rivaroxaban
evaluation of the transparency committee
rivaroxaban
administration, oral
factor xa
pulmonary embolism
anticoagulants
anticoagulants
adult
venous thrombosis
deep vein thrombosis
pulmonary embolism
insurance, health, reimbursement
treatment outcome

---
https://www.minerva-ebp.be/fr/analyses-en-ligne/152
2013
false
false
minerva-ebm.be
Belgium
French
Factor Xa Inhibitors
Rivaroxaban
critical appraisal or critical reading
immobilization
factor xa
adult
enoxaparin
anticoagulants
hemorrhage
venous thromboembolism
rivaroxaban
Product containing rivaroxaban (medicinal product)

---
http://www.pharmactuel.com/index.php/pharmactuel/article/view/890
2013
false
false
Canada
French
Rivaroxaban
Rivaroxaban
treatment outcome
rivaroxaban
anticoagulants
anticoagulants
clinical trials, phase iii as topic
critical appraisal or critical reading
acute coronary syndrome

---
https://www.ema.europa.eu/medicines/human/EPAR/Xarelto
2013
false
United Kingdom
English
French
secondary prevention
recurrence
Factor Xa Inhibitors
syndication feed
Rivaroxaban
Rivaroxaban
tablets
administration, oral
adult
fibrinolytic agents
fibrinolytic agents
drug approval
drug labeling
treatment outcome
venous thromboembolism
arthroplasty, replacement, hip
arthroplasty, replacement, knee
postoperative complications
factor xa
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
drug evaluation
summary of product characteristics
package leaflet
rivaroxaban
stroke
embolism
atrial fibrillation
venous thrombosis
venous thrombosis
deep vein thrombosis
deep vein thrombosis
pulmonary embolism
pulmonary embolism
acute coronary syndrome
thrombosis

---
http://www.has-sante.fr/portail/jcms/c_1269786/xarelto-rivaroxaban-anticoagulant-oral
2012
false
France
French
guidelines for drug use
evaluation of the transparency committee
secondary prevention
Factor Xa Inhibitors
Rivaroxaban
Rivaroxaban
deep vein thrombosis
venous thrombosis
administration, oral
anticoagulants
anticoagulants
factor xa
pulmonary embolism
venous thrombosis
deep vein thrombosis
treatment outcome
insurance, health, reimbursement
acute disease
adult
rivaroxaban
comparative study

---
http://www.has-sante.fr/portail/jcms/c_1269705/xarelto-rivaroxaban-anticoagulant-oral
2012
false
France
French
guidelines for drug use
evaluation of the transparency committee
Factor Xa Inhibitors
Rivaroxaban
Rivaroxaban
administration, oral
insurance, health, reimbursement
treatment outcome
factor xa
anticoagulants
anticoagulants
aged
adult
stroke
thromboembolism
atrial fibrillation
risk factors
continuity of patient care
randomized controlled trials as topic
rivaroxaban
comparative study

---
http://www.inesss.qc.ca/fileadmin/doc/INESSS/Rapports/Medicaments/INESSS_outil_choix_anticoagulotherapie.pdf
2012
false
true
false
Canada
factor xa
anticoagulants
anticoagulants
anticoagulants
anticoagulants
Rivaroxaban
technical report
atrial fibrillation
adult

---
http://www.has-sante.fr/portail/jcms/c_1241674/fr/xarelto?xtmc=&xtcr=4
2012
true
France
French
evaluation of the transparency committee
Factor Xa Inhibitors
Rivaroxaban
Rivaroxaban
administration, oral
insurance, health, reimbursement
anticoagulants
anticoagulants
factor xa
stroke
embolism
adult
atrial fibrillation
atrial fibrillation
risk factors
aged
treatment outcome
clinical trials, phase iii as topic
rivaroxaban

---
https://www.minerva-ebp.be/fr/article/245
2011
false
true
false
false
minerva-ebm.be
Belgium
enoxaparin
venous thrombosis
Rivaroxaban
critical appraisal or critical reading
venous thrombosis

---
https://www.minerva-ebp.be/fr/article/208
2011
false
false
minerva-ebm.be
Belgium
French
Dutch
critical appraisal or critical reading
Factor Xa Inhibitors
Rivaroxaban
Rivaroxaban
anticoagulants
atrial fibrillation
administration, oral
treatment outcome
factor xa
warfarin
stroke
embolism
anticoagulants
atrial fibrillation
hemorrhage
warfarin
double-blind method
warfarin
vitamin K
rivaroxaban
comparative study

---
https://www.cadth.ca/sites/default/files/pdf/R0004_Anticoagulants_for_Atrial_Fibrillation_cetap_f.pdf
2010
true
Canada
French
Rivaroxaban
Dabigatran
stroke
atrial fibrillation
administration, oral
canada
treatment outcome
Evidence-Based medicine
dabigatran etexilate
anticoagulants
drug evaluation
rivaroxaban
journal article

---
https://pgtmsite.files.wordpress.com/2024/01/rivaroxaban_es_20100209.pdf
2010
Canada
drug information
Rivaroxaban
Rivaroxaban
rivaroxaban

---
http://www.cbip.be/Folia/Index.cfm?FoliaWelk=F37F03B
2010
false
Belgium
French
anticoagulotherapy
Rivaroxaban
Dabigatran
venous thromboembolism
anticoagulants
administration, oral
dabigatran etexilate
postoperative complications
orthopedic procedures
treatment outcome
dabigatran etexilate mesylate
journal article
rivaroxaban

---
http://www.has-sante.fr/portail/jcms/c_812160/xarelto-rivaroxaban-anticoagulant-oral
2009
false
France
French
Factor Xa Inhibitors
Rivaroxaban
venous thromboembolism
arthroplasty, replacement, hip
arthroplasty, replacement, knee
insurance, health, reimbursement
anticoagulants
administration, oral
factor xa
adult
evaluation of the transparency committee
rivaroxaban

---
https://www.minerva-ebp.be/fr/article/462
2009
false
minerva-ebm.be
Belgium
French
Rivaroxaban
venous thromboembolism
arthroplasty, replacement, knee
fibrinolytic agents
critical appraisal or critical reading
rivaroxaban

---
Nous contacter.
27/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.